161 related articles for article (PubMed ID: 15531106)
1. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity.
Weise J; Crome O; Sandau R; Schulz-Schaeffer W; Bähr M; Zerr I
Neurosci Lett; 2004 Nov; 372(1-2):146-50. PubMed ID: 15531106
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cellular prion protein alters postischemic Erk1/2 phosphorylation but not Akt phosphorylation and protects against focal cerebral ischemia.
Weise J; Doeppner TR; Müller T; Wrede A; Schulz-Schaeffer W; Zerr I; Witte OW; Bähr M
Restor Neurol Neurosci; 2008; 26(1):57-64. PubMed ID: 18431006
[TBL] [Abstract][Full Text] [Related]
3. Physiological role of the cellular prion protein (PrPc): protein profiling study in two cell culture systems.
Ramljak S; Asif AR; Armstrong VW; Wrede A; Groschup MH; Buschmann A; Schulz-Schaeffer W; Bodemer W; Zerr I
J Proteome Res; 2008 Jul; 7(7):2681-95. PubMed ID: 18537284
[TBL] [Abstract][Full Text] [Related]
4. Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1.
Spudich A; Frigg R; Kilic E; Kilic U; Oesch B; Raeber A; Bassetti CL; Hermann DM
Neurobiol Dis; 2005 Nov; 20(2):442-9. PubMed ID: 15893468
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
[TBL] [Abstract][Full Text] [Related]
6. Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain.
Bailly Y; Haeberlé AM; Blanquet-Grossard F; Chasserot-Golaz S; Grant N; Schulze T; Bombarde G; Grassi J; Cesbron JY; Lemaire-Vieille C
J Comp Neurol; 2004 May; 473(2):244-69. PubMed ID: 15101092
[TBL] [Abstract][Full Text] [Related]
7. The role of the octarepeat region in neuroprotective function of the cellular prion protein.
Mitteregger G; Vosko M; Krebs B; Xiang W; Kohlmannsperger V; Nölting S; Hamann GF; Kretzschmar HA
Brain Pathol; 2007 Apr; 17(2):174-83. PubMed ID: 17388948
[TBL] [Abstract][Full Text] [Related]
8. Effects of transient focal cerebral ischemia in mice deficient in puma.
Kuroki K; Virard I; Concannon CG; Engel T; Woods I; Taki W; Plesnila N; Henshall DC; Prehn JH
Neurosci Lett; 2009 Feb; 451(3):237-40. PubMed ID: 19159665
[TBL] [Abstract][Full Text] [Related]
9. Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke.
Mitsios N; Saka M; Krupinski J; Pennucci R; Sanfeliu C; Miguel Turu M; Gaffney J; Kumar P; Kumar S; Sullivan M; Slevin M
J Neurosci Res; 2007 Feb; 85(3):602-11. PubMed ID: 17149767
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
[TBL] [Abstract][Full Text] [Related]
11. Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrP in mouse cerebral microvessels and brain parenchyma.
Williams WM; Stadtman ER; Moskovitz J
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):161-8. PubMed ID: 15043713
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
Xanthopoulos K; Paspaltsis I; Apostolidou V; Petrakis S; Siao CJ; Kalpatsanidis A; Grigoriadis N; Tsaftaris A; Tsirka SE; Sklaviadis T
Neurobiol Dis; 2005 Nov; 20(2):519-27. PubMed ID: 15922607
[TBL] [Abstract][Full Text] [Related]
13. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
[TBL] [Abstract][Full Text] [Related]
14. Prion protein accumulation and neuroprotection in hypoxic brain damage.
McLennan NF; Brennan PM; McNeill A; Davies I; Fotheringham A; Rennison KA; Ritchie D; Brannan F; Head MW; Ironside JW; Williams A; Bell JE
Am J Pathol; 2004 Jul; 165(1):227-35. PubMed ID: 15215178
[TBL] [Abstract][Full Text] [Related]
15. Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse.
Benvegnù S; Poggiolini I; Legname G
J Comp Neurol; 2010 Jun; 518(11):1879-91. PubMed ID: 20394048
[TBL] [Abstract][Full Text] [Related]
16. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
Barber PA; Hoyte L; Kirk D; Foniok T; Buchan A; Tuor U
Neurosci Lett; 2005 Nov; 388(1):54-9. PubMed ID: 16055267
[TBL] [Abstract][Full Text] [Related]
17. Regional and phenotype heterogeneity of cellular prion proteins in the human brain.
Kuczius T; Koch R; Keyvani K; Karch H; Grassi J; Groschup MH
Eur J Neurosci; 2007 May; 25(9):2649-55. PubMed ID: 17466020
[TBL] [Abstract][Full Text] [Related]
18. New insights into cellular prion protein (PrPc) functions: the "ying and yang" of a relevant protein.
Nicolas O; Gavín R; del Río JA
Brain Res Rev; 2009 Oct; 61(2):170-84. PubMed ID: 19523487
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leukotriene receptors CysLT1 and CysLT2 are upregulated in acute neuronal injury after focal cerebral ischemia in mice.
Zhang YJ; Zhang L; Ye YL; Fang SH; Zhou Y; Zhang WP; Lu YB; Wei EQ
Acta Pharmacol Sin; 2006 Dec; 27(12):1553-60. PubMed ID: 17112408
[TBL] [Abstract][Full Text] [Related]
20. Cellular prion protein signaling in serotonergic neuronal cells.
Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
